XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ equity (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2023
$ / shares
Sep. 30, 2022
USD ($)
$ / shares
Jun. 30, 2022
USD ($)
Mar. 31, 2022
$ / shares
shares
Mar. 31, 2022
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2015
Shares acquired pursuant value | $           $ 79,705            
Number of options cancelled                 460,000   285,600  
Gain on derivative liability | $                 $ 51   $ 23,314  
Derivative liability | $                 $ 51  
Share-based compensation arrangement, percentage of outstanding stock maximum                       10.00%
Number of options granted                 1,885,000   2,550,000  
Share-based compensation arrangement, grants in period, weighted average exercise price (in CAD per share) | $ / shares                 $ 0.30   $ 0.40  
Number of options expired unexercised                 1,988,000   506,150  
Aggregate intrinsic value for options | $                  
Share-based payment arrangement, expense | $ 135,867       $ 181,129       $ 384,188 $ 525,721    
Maximum [Member]                        
Share-based compensation arrangement, expiration period (Year)                       10 years
Stock Option Plan 2015 [Member]                        
Share-based compensation arrangement, percentage of outstanding stock maximum                       10.00%
Share-based payment arrangement, expense | $ $ 135,867       $ 181,129              
Share-based compensation arrangement, weighted average grant | $ / shares $ 0.28       $ 0.31              
Stock Option Plan 2015 [Member] | Employee Stock Options [Member]                        
Number of options cancelled 330,000                      
Number of options granted     2,550,000       1,885,000 1,885,000        
Share-based compensation arrangement, grants in period, weighted average exercise price (in CAD per share) | (per share)     $ 0.40 $ 0.50     $ 0.22 $ 0.30        
Number of options expired unexercised   1,988,000                    
TSXV [Member]                        
Shares acquired pursuant                     6,579,074  
Percentage of issued and outstanding shares                     5.00%  
NCIB [Member]                        
Shares acquired pursuant     43,500               275,000  
Shares acquired pursuant value | $                     $ 87,778  
Number of options cancelled                     233,500  
Shares cancelled value | $     $ 12,310